Overcoming inefficiencies to improve access to cell and gene therapy
Drug Discovery World
MARCH 13, 2023
While there is no silver bullet for increasing the availability of CGTs, improving manufacturing processes that enable their development at scale can help reduce the cost of these treatments and get them to those who need them most. In reality, the situation revealed that, before the pandemic, many in the industry failed to plan well.
52 
Let's personalize your content